Regeneron Pharmaceuticals, Inc. (REGN)
807.71
-7.08
(-0.87%)
USD |
NASDAQ |
Aug 27, 16:00
810.37
+2.66
(+0.33%)
After-Hours: 20:00
Regeneron Pharmaceuticals Total Return Price : 807.71 for Aug. 27, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| August 27, 2026 | 807.71 |
| August 26, 2026 | 814.79 |
| August 25, 2026 | 833.56 |
| August 24, 2026 | 828.50 |
| August 21, 2026 | 834.04 |
| August 20, 2026 | 826.64 |
| August 19, 2026 | 840.84 |
| August 18, 2026 | 810.24 |
| August 17, 2026 | 804.99 |
| August 14, 2026 | 802.54 |
| August 13, 2026 | 805.03 |
| August 12, 2026 | 797.06 |
| August 11, 2026 | 796.07 |
| August 10, 2026 | 807.11 |
| August 07, 2026 | 783.45 |
| August 06, 2026 | 771.21 |
| August 05, 2026 | 767.68 |
| August 04, 2026 | 759.77 |
| August 03, 2026 | 758.35 |
| July 31, 2026 | 761.74 |
| July 30, 2026 | 737.48 |
| July 29, 2026 | 694.61 |
| July 28, 2026 | 694.37 |
| July 27, 2026 | 666.39 |
| July 24, 2026 | 655.24 |
| Date | Value |
|---|---|
| July 23, 2026 | 651.15 |
| July 22, 2026 | 650.42 |
| July 21, 2026 | 674.40 |
| July 20, 2026 | 671.37 |
| July 17, 2026 | 675.90 |
| July 16, 2026 | 678.15 |
| July 15, 2026 | 663.68 |
| July 14, 2026 | 655.35 |
| July 13, 2026 | 662.32 |
| July 10, 2026 | 663.74 |
| July 09, 2026 | 667.17 |
| July 08, 2026 | 662.11 |
| July 07, 2026 | 675.44 |
| July 06, 2026 | 649.05 |
| July 02, 2026 | 653.51 |
| July 01, 2026 | 623.99 |
| June 30, 2026 | 622.81 |
| June 29, 2026 | 631.07 |
| June 26, 2026 | 632.16 |
| June 25, 2026 | 619.42 |
| June 24, 2026 | 622.70 |
| June 23, 2026 | 617.31 |
| June 22, 2026 | 611.79 |
| June 18, 2026 | 609.23 |
| June 17, 2026 | 607.22 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Alnylam Pharmaceuticals, Inc. | 236.56 |
| Gilead Sciences, Inc. | 148.86 |
| AbbVie, Inc. | 258.15 |
| Vertex Pharmaceuticals, Inc. | 547.55 |
| Amgen, Inc. | 436.99 |